NanoSomiX Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
NanoSomiX General Information
Description
Developer of brain analytic tools designed to detect neurological disorders. The company's tools utilize blood-based assay technology for further biomarker exploration in neurodegenerative diseases focusing on exosomes produced by various brain cell populations, enabling hospitals to get insights into neurological disorders via routine blood tests.
Contact Information
Website
www.nanosomix.comCorporate Office
- 27068 La Paz Road
- Suite 555
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 27068 La Paz Road
- Suite 555
- Aliso Viejo, CA 92656
- United States
NanoSomiX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 29-Apr-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Angel (individual) | Completed | Startup |
NanoSomiX Comparisons
Industry
Financing
Details
NanoSomiX Competitors (36)
One of NanoSomiX’s 36 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Fauna Bio | Venture Capital-Backed | Emeryville, CA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| Genespire | Venture Capital-Backed | Milan, Italy |
NanoSomiX Patents
NanoSomiX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260318925-A1 | Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders | Pending | 04-Nov-2024 | ||
| WO-2026076444-A1 | Biomarkers for the assessment of post-hemorrhagic stroke | Pending | 04-Oct-2024 | ||
| US-20250306038-A1 | Blood biomarkers of oligodendrocyte-derived exosomes and their use in identifying asymptomatic brain injury | Pending | 01-Apr-2024 | ||
| WO-2025212670-A1 | Blood biomarkers of oligodendrocyte-derived exosomes and their use in identifying asymptomatic brain injury | Pending | 01-Apr-2024 | ||
| WO-2024178194-A1 | Assay and methods for use in the care and diagnosis of stroke patients | Inactive | 22-Feb-2023 | G01N33/5091 |
NanoSomiX FAQs
-
When was NanoSomiX founded?
NanoSomiX was founded in 2014.
-
Where is NanoSomiX headquartered?
NanoSomiX is headquartered in Aliso Viejo, CA.
-
What industry is NanoSomiX in?
NanoSomiX’s primary industry is Biotechnology.
-
Is NanoSomiX a private or public company?
NanoSomiX is a Private company.
-
What is NanoSomiX’s current revenue?
The current revenue for NanoSomiX is .
-
Who are NanoSomiX’s competitors?
Regenxbio, Alzheon, Fauna Bio, Genetix Biotherapeutics, and Genespire are some of the 36 competitors of NanoSomiX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process